What are the optimal timing windows for TREM2 agonism vs antagonism across disease progression stages? — Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-11-gap-debate-20260410-112636-141592ba. The debate highlighted that TREM2 therapeutic targeting remains contested across disease stages, but no clear framework exists for when to activate versus inhibit TREM2 signaling.

📊 Related Analysis: What are the optimal timing windows for TREM2 agonism vs antagonism across disease progression stages? (neurodegeneration)
Created: 2026-04-12

No Rendered Output

This notebook has not been rendered to HTML yet.